Yohimbine

Yohimbine

SCHEMBL33954

COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 9/20 1.00
ADRA1A P35348 8/20 1.00
CYP2D6 P10635 7/20 1.00
ADRA2C P18825 6/20 1.00
ADRA2B P18089 5/20 1.00
ADRA1B P35368 4/20 1.00
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
CYP3A4 P08684 3/20 1.00
ADRA1D P25100 3/20 1.00
PMP22 Q01453 3/20 1.00
HSD17B10 Q99714 3/20 1.00
KDM4E B2RXH2 2/20 1.00
LMNA P02545 2/20 1.00
CYP1A2 P05177 2/20 1.00
TSHR P16473 2/20 1.00
HTR1A P08908 2/20 1.00
THRB P10828 2/20 1.00
HPGD P15428 2/20 1.00
HTR1B P28222 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Yohimbine SCHEMBL9622911 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL10020758 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL18120971 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL564078 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL25366080 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL8097702 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL23244673 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL13932206 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL22703462 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B
Rauwolscine SCHEMBL4548294 1.00 ADRA2A (1.00) ADRA2AADRA1ACYP2D6ADRA2CADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13201 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144798-A1 Disruption of Vascular Smooth Muscle Relaxation by Carfilzomib May be the Primary Reason for CFZ-Induced Vascular Dysfunction AMGEN INC. (US) 2026-05-28 US claimed
CN-122056948-A Uncaria alkaloid extract and preparation method and application thereof 华南理工大学 2026-05-19 CN claimed
EP-4725483-A1 COMBINATION COMPRISING AT LEAST ONE 5-HT2A RECEPTOR ANTAGONIST AND AT LEAST ONE 5-HT3 RECEPTOR ANTAGONIST AND ITS MEDICAL USE Université de Bordeaux (FR) 2026-04-15 EP claimed
EP-4724125-A1 APPARATUS, METHODS, AND SYSTEMS FOR ATOMIZED DELIVERY OF A COMPOSITION TO A PATIENT Microneb Tech Holdings, Inc. (US) 2026-04-15 EP claimed
US-12533327-B2 Hexylamine salts and methods of using hexylamine THERMOLIFE INTERNATIONAL, LLC (US) 2026-01-27 US claimed
EP-4676470-A2 DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF Ingenious Ingredients, LP (US) 2026-01-14 EP claimed
US-20250367206-A1 1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF Ingenious Ingredients, LP (US) 2025-12-04 US claimed
US-20250360137-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES FREEDOM BIOSCIENCES INC (US) 2025-11-27 US claimed
WO-2025229086-A1 ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF SKINOSIVE (FR) 2025-11-06 WO claimed
US-12434068-B2 Accessing spinal networks to address sexual dysfunction THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-10-07 US claimed
EP-0236251-A2 2-(2-aminobenzyl)-1,2,3,4-tetrahydroisoquinolines, processes for obtaining them and pharmaceutical compositions containing them UNIVERSITE LOUIS PASTEUR (STRASBOURG I) (FR) 1987-09-09 EP claimed
US-4659714-A PROLONGATION WITH VASOCONSTRICTORS; REVERSAL WITH ADRENERGIC BLOCKING AGENTS DENTSPLY, LTD. (GB) 1987-04-21 US claimed
EP-0217688-A1 Peptide derivatives with a lactonic or cycloamidic structure, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1987-04-08 EP claimed
US-4588724-A Treatment for selective reduction of regional fat deposits GREENWAY FRANK L III (US) 1986-05-13 US claimed
EP-0160191-A1 Kit for treating mammals Dentsply Limited (GB) 1985-11-06 EP claimed
US-4532135-A Treating renal damage by administering vasodilator having postsynaptic alpha-adrenoceptor blocking activity and antihyperlipidemic characteristics EDWARDS K DAVID G 1985-07-30 US claimed
EP-0120165-A2 A preparation and a process for achieving regional weight control Greenway III, Frank L. (US) 1984-10-03 EP claimed
EP-0105361-A1 ANTAGONISM OF CENTRAL NERVOUS SYSTEM DRUGS BY THE ADMINISTRATION OF 4-AMINOPYRIDINE ALONE OR IN COMBINATION WITH OTHER DRUGS THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1984-04-18 EP claimed
WO-1983003541-A1 ANTAGONISM OF CENTRAL NERVOUS SYSTEM DRUGS BY THE ADMINISTRATION OF 4-AMINOPYRIDINE ALONE OR IN COMBINATION WITH OTHER DRUGS UNIV GEORGIA RES FOUND (US) 1983-10-27 WO claimed
US-4310524-A TCA Composition and method for rapid onset antidepressant therapy RICHARDSON-MERRELL, INC. (US) 1982-01-12 US claimed